Novartis enters agreement to acquire Mariana Oncology, …

Basel, May 2, 2024 – Novartis today announced that it has entered into an agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, …

CouponFollow Extension

$1
OFF

Novartis Extends Its Reach In Radiopharmaceuticals With $1B …

20 hours ago

May 2, 2024 · Mariana Oncology brings Novartis a lead radiopharmaceutical program in development for small cell lung cancer. ... the company said it was preparing to advance MC …

medcitynews.com

$1.75
OFF

Novartis To Buy Mariana Oncology For Up To $1.75 Billion In Boost …

20 hours ago

May 2, 2024 · Novartis agreed to acquire U.S. biotechnology company Mariana Oncology for up to $1.75 billion, in a deal that bolsters its radioligand therapy pipeline and efforts to develop …

morningstar.com

$1
OFF

Novartis Entrenches Into Radiopharma With $1B Mariana Buy

20 hours ago

May 2, 2024 · With much still to discover in the massive world of radiopharmaceuticals, Novartis will take a deep dive into the unknown with Mariana Oncology in a $1 billion upfront …

fiercebiotech.com

$1
OFF

Mariana Oncology To Be Acquired By Novartis For $1 Billion …

20 hours ago

May 2, 2024 · The Life Sciences team advised Mariana Oncology on its acquisition by Novartis for $1 billion upfront and up to $750 million in potential milestone payments. The acquisition …

goodwinlaw.com

$1
OFF

Novartis To Buy Mariana Oncology, Paying $1 Billion Upfront

20 hours ago

May 2, 2024 · Novartis to Buy Mariana Oncology, Paying $1 Billion Upfront. Radiopharma firms are sought after by large drugmakers; Novartis may make up to $750 million in milestone …

bloomberg.com

$1
OFF

Novartis Extends Radiopharma Plans With $1 Billion Acquisition

20 hours ago

May 2, 2024 · Novartis is paying $1 billion upfront and up to an additional $750 million if certain milestones are met to acquire startup Mariana Oncology, the latter company announced …

statnews.com

FAQs about Novartis enters agreement to acquire Mariana Oncology, … Coupon?

Will Mariana oncology be acquired by Novartis?

Watertown, Mass., May 2, 2024 – Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer, today announced it will be acquired by Novartis for $1 billion upfront and up to $750 million in potential milestone payments. ...

What's new at Mariana oncology?

This journey has brought us to a new name: We are now Mariana Oncology Check back here for the latest on Mariana Oncology. Acquisition of Mariana Oncology brings together two companies at the forefront of novel radiopharmaceutical development, with a total potential value of up to $1.75 billion ...

What is Mariana oncology worth?

Acquisition of Mariana Oncology brings together two companies at the forefront of novel radiopharmaceutical development, with a total potential value of up to $1.75 billion ...

Who owns Mariana oncology?

This follows an oversubscribed $175 million Series B financing in Mariana Oncology in September 2023 co-led by Forbion and Deep Track Capital, alongside founding investors Atlas Venture, Access Biotechnology, RA Capital Management and new investors Nextech Invest, Surveyor Capital (a Citadel company) and Eli Lilly and Company. ...

How much will Novartis pay Mariana shareholders?

According to the deal terms announced Thursday, Novartis is paying $1 billion up front. Milestone payments could bring the Mariana shareholders another $750 million. Novartis is already a leader in radiopharmaceuticals with two commercialized therapies, Lutathera for gastroenteropancreatic neuroendocrine tumors and Pluvicto for prostate cancer. ...

What makes Mariana oncology unique?

Together, we offer a compelling combination of capabilities,” said Simon Read, Founder and CEO, Mariana Oncology. “In the short time since founding the company, the team at Mariana Oncology has developed a leading radiopharmaceutical discovery platform and an innovative pipeline. ...